53 results
S-3ASR
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
for the period of its appointment or, if indicated in the applicable prospectus supplement, on a firm commitment basis. This prospectus may be used … with dealers, acting as standby underwriters. We may pay the standby underwriters a commitment fee for the securities they commit to purchase
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
10 Jul 23
Regulation FD Disclosure
4:06pm
, as potential in other potential in PWS, financing commitment hyperphagia, behaviors, well as protection of indications an orphan indication from Nantahala … Manufacturing Hub Services Patients Product Distribution 28 | © 2023 Soleno Therapeutics
FINANCIAL INFORMATION
Up to $60m financing commitment Leading
8-K
EX-99.1
SLNO
Soleno Therapeutics Inc
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
Exhibit 99.1
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
Funding from Three Leading Healthcare Investors, with Vivo … to $60 million.
“This commitment from top-tier investors is a significant demonstration of confidence ahead of expected data from the randomized
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
calling for the issuance of, and there is no commitment, plan or arrangement to issue, any share of stock of the Company or any of its subsidiaries
424B5
olyummw
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
irra4
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-99.1
gv4sgdu8
5 May 21
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:01pm
8-K
b2cq57kj
15 Apr 21
Other Events
12:00am
8-K
EX-99.2
h1o3d2beg3jpk3uy
15 Apr 21
Other Events
12:00am
8-K
EX-1.1
yz87u
25 Oct 19
Soleno Therapeutics Announces Pricing of $13.4 Million Public Offering of Common Stock
4:03pm
424B5
aqxukuv9e0six93gnbz
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
vn8ce5iyy nuf
22 Oct 19
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.1
lt9tv5
29 Apr 19
Soleno Therapeutics Announces Appointment of Industry Veteran Gwen A. Melincoff to Board of Directors
4:03pm
424B3
l3if5o5a3iom4xbejflo
12 Apr 19
Prospectus supplement
4:41pm
8-K
EX-10.1
hxvkw4fw6gr74
19 Dec 18
Soleno Therapeutics Announces $16.5 Million Private Placement
4:02pm